55 related articles for article (PubMed ID: 35633536)
21. PaccMann: a web service for interpretable anticancer compound sensitivity prediction.
Cadow J; Born J; Manica M; Oskooei A; Rodríguez Martínez M
Nucleic Acids Res; 2020 Jul; 48(W1):W502-W508. PubMed ID: 32402082
[TBL] [Abstract][Full Text] [Related]
22. LigRMSD: a web server for automatic structure matching and RMSD calculations among identical and similar compounds in protein-ligand docking.
Velázquez-Libera JL; Durán-Verdugo F; Valdés-Jiménez A; Núñez-Vivanco G; Caballero J
Bioinformatics; 2020 May; 36(9):2912-2914. PubMed ID: 31926012
[TBL] [Abstract][Full Text] [Related]
23. TP53 in bone and soft tissue sarcomas.
Thoenen E; Curl A; Iwakuma T
Pharmacol Ther; 2019 Oct; 202():149-164. PubMed ID: 31276706
[TBL] [Abstract][Full Text] [Related]
24. PrankWeb: a web server for ligand binding site prediction and visualization.
Jendele L; Krivak R; Skoda P; Novotny M; Hoksza D
Nucleic Acids Res; 2019 Jul; 47(W1):W345-W349. PubMed ID: 31114880
[TBL] [Abstract][Full Text] [Related]
25. Nano based drug delivery systems: recent developments and future prospects.
Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Epidemiology, Clinical Features, and Outcomes of Patients with Reported Ewing Sarcoma and PNET over 40 Years Justifies Current WHO Classification and Treatment Approaches.
Campbell K; Shulman D; Janeway KA; DuBois SG
Sarcoma; 2018; 2018():1712964. PubMed ID: 30158829
[TBL] [Abstract][Full Text] [Related]
27. Ewing sarcoma.
Grünewald TGP; Cidre-Aranaz F; Surdez D; Tomazou EM; de Álava E; Kovar H; Sorensen PH; Delattre O; Dirksen U
Nat Rev Dis Primers; 2018 Jul; 4(1):5. PubMed ID: 29977059
[TBL] [Abstract][Full Text] [Related]
28. ADVERPred-Web Service for Prediction of Adverse Effects of Drugs.
Ivanov SM; Lagunin AA; Rudik AV; Filimonov DA; Poroikov VV
J Chem Inf Model; 2018 Jan; 58(1):8-11. PubMed ID: 29206457
[TBL] [Abstract][Full Text] [Related]
29. ROSC-Pred: web-service for rodent organ-specific carcinogenicity prediction.
Lagunin A; Rudik A; Druzhilovsky D; Filimonov D; Poroikov V; Wren J
Bioinformatics; 2018 Feb; 34(4):710-712. PubMed ID: 29069300
[TBL] [Abstract][Full Text] [Related]
30. miR-708-5p: a microRNA with emerging roles in cancer.
Monteleone NJ; Lutz CS
Oncotarget; 2017 Sep; 8(41):71292-71316. PubMed ID: 29050362
[TBL] [Abstract][Full Text] [Related]
31. NuBBE
Pilon AC; Valli M; Dametto AC; Pinto MEF; Freire RT; Castro-Gamboa I; Andricopulo AD; Bolzani VS
Sci Rep; 2017 Aug; 7(1):7215. PubMed ID: 28775335
[TBL] [Abstract][Full Text] [Related]
32. QSAR Modelling of Rat Acute Toxicity on the Basis of PASS Prediction.
Lagunin A; Zakharov A; Filimonov D; Poroikov V
Mol Inform; 2011 Mar; 30(2-3):241-50. PubMed ID: 27466777
[TBL] [Abstract][Full Text] [Related]
33. EWING'S SARCOMA: EPIDEMIOLOGY AND PROGNOSIS FOR PATIENTS TREATED AT THE PEDIATRIC ONCOLOGY INSTITUTE, IOP-GRAACC-UNIFESP.
Bellan DG; Filho RJ; Garcia JG; de Toledo Petrilli M; Maia Viola DC; Schoedl MF; Petrilli AS
Rev Bras Ortop; 2012; 47(4):446-50. PubMed ID: 27047848
[TBL] [Abstract][Full Text] [Related]
34. Increased cathepsin D protein expression is a biomarker for osteosarcomas, pulmonary metastases and other bone malignancies.
Gemoll T; Epping F; Heinrich L; Fritzsche B; Roblick UJ; Szymczak S; Hartwig S; Depping R; Bruch HP; Thorns C; Lehr S; Paech A; Habermann JK
Oncotarget; 2015 Jun; 6(18):16517-26. PubMed ID: 26203049
[TBL] [Abstract][Full Text] [Related]
35. Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis.
El-Naggar AM; Veinotte CJ; Cheng H; Grunewald TG; Negri GL; Somasekharan SP; Corkery DP; Tirode F; Mathers J; Khan D; Kyle AH; Baker JH; LePard NE; McKinney S; Hajee S; Bosiljcic M; Leprivier G; Tognon CE; Minchinton AI; Bennewith KL; Delattre O; Wang Y; Dellaire G; Berman JN; Sorensen PH
Cancer Cell; 2015 May; 27(5):682-97. PubMed ID: 25965573
[TBL] [Abstract][Full Text] [Related]
36. EWS-FLI1 employs an E2F switch to drive target gene expression.
Schwentner R; Papamarkou T; Kauer MO; Stathopoulos V; Yang F; Bilke S; Meltzer PS; Girolami M; Kovar H
Nucleic Acids Res; 2015 Mar; 43(5):2780-9. PubMed ID: 25712098
[TBL] [Abstract][Full Text] [Related]
37. Therapy resistance mechanisms in Ewing's sarcoma family tumors.
Ahmed AA; Zia H; Wagner L
Cancer Chemother Pharmacol; 2014 Apr; 73(4):657-63. PubMed ID: 24469502
[TBL] [Abstract][Full Text] [Related]
38. Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell lines.
May WA; Grigoryan RS; Keshelava N; Cabral DJ; Christensen LL; Jenabi J; Ji L; Triche TJ; Lawlor ER; Reynolds CP
PLoS One; 2013; 8(12):e80060. PubMed ID: 24312454
[TBL] [Abstract][Full Text] [Related]
39. DIGEP-Pred: web service for in silico prediction of drug-induced gene expression profiles based on structural formula.
Lagunin A; Ivanov S; Rudik A; Filimonov D; Poroikov V
Bioinformatics; 2013 Aug; 29(16):2062-3. PubMed ID: 23740741
[TBL] [Abstract][Full Text] [Related]
40. GalaxyRefine: Protein structure refinement driven by side-chain repacking.
Heo L; Park H; Seok C
Nucleic Acids Res; 2013 Jul; 41(Web Server issue):W384-8. PubMed ID: 23737448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
